The Office of Translation to Practice (OTP) is housed in the Center for Clinical and Translational Sciences at Mayo Clinic. Established in 2015, the office is tasked with developing and managing novel tools, mechanisms, and processes to facilitate and accelerate the translation of products, such as drugs, biological agents, and medical devices, into practice. Since its inception, OTP is credited

INTRODUCTION Under-representation in health-related research is one of a multitude of factors that contribute to health disparities experienced by African American and Latinx communities, and has been brought to the forefront in the context of the COVID-19 pandemic. Barriers to research participation stem from historical social injustices, are multi-faceted and include factors specific to the

The Georgia CTSA Rapid Response Team expedited high-priority studies of experimental therapeutics and vaccines. Emory's first COVID-19 patient began receiving infusion therapy of Remdesivir within 48 hours as a result of Georgia CTSA's assistance in coordinating the approvals needed. Representatives from Emory research offices worked together in parallel to expedite 27 COVID-19 studies from March

The University of Pittsburgh Clinical and Translational Science Institute (CTSI) launched the optional Innovation Core in 2015 with three aims: 1) Develop advanced, experiential innovation training, networking and externship opportunities and support the academic career development for biomedical innovators; 2) Develop and disseminate new methods and processes that encourage and support innovative

As a result of the CTSA Program’s objective to strengthen multidisciplinary research infrastructure, hubs are uniquely poised to mobilize their vast resources to produce a rapid, nimble, multi-faceted approach to national public health emergencies. The Institute of Clinical and Translational Sciences, the CTSA grantee at Washington University in St. Louis, is a critical contributor to the

Recognizing the diversity of populations within California and the disproportionate burden of COVID-19 on minority and low income communities, we have formed a statewide community-partnered collaborative funded by the NIH/NHLBI to address disparities in COVID-19 knowledge, awareness, and communication; vaccine trial participation; and vaccine hesitancy and accessibility. The statewide

Background: Engaging and understanding the perspectives of community stakeholders, including patients and their caregivers, is a critical component of all phases of clinical and translational research. Community engagement can facilitate efforts to identify health needs and priorities, provide critical input and data, and improve recruitment and retention for clinical research studies. The

Abstract Discovering effective methods to prevent, track, and treat COVID-19 is critical to improve outcomes and save lives. We designed a registry to phenotype the cohort of COVID-19 patients from the Electronic Health Record and developed a visualizer for inpatient data for researchers and clinical care teams. The main goals of the registry were to rapidly identify early risk factors; enable

We present our optional module to reduce imaging variability in multisite studies. We built research infrastructure to enable management and analysis of standardized images. NIX is now a functioning international alliance. The D&I Launchpad provides training, resources, and support for rigorous dissemination and sustainable implementation of evidence-based interventions with health systems. The